Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The changing spectrum of hypertension in premature infants

Abstract

Objective

The objective is to document changes in the etiologic spectrum of hypertension in premature infants.

Study design

We reviewed all cases of systemic hypertension (HTN) in premature infants at two centers over 8 years. Infants were sorted into categorical groups as described in 2012 by Flynn. Analyses included frequency of diagnosis, timecourse of HTN, and diagnostics. Phthalate exposure via intravenous fluid and respiratory equipment was compared among groups and centers.

Results

One hundred and twenty-nine infants having 130 episodes of HTN met the inclusion criteria. Sixty-five percent of cases were classified as pulmonary and 16% as miscellaneous. Plasma renin activity (PRA) was undetectable or <11 ng/mL/h in almost all hypertensive infants. Cases categorized as Pulmonary, medications/intoxications, and miscellaneous presented near 40 weeks postmenstrual age, with low PRA and large phthalate exposures.

Conclusions

High PRA HTN has been replaced by low PRA in most cases, and may be due to phthalate exposure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Adelman RD. Neonatal hypertension. Pediatr Clin N Am. 1978;25:99–110.

    Article  CAS  Google Scholar 

  2. Neal WA, Reynolds JW, Jarvis CW, Williams HJ. Umbilical artery catheterization: demonstration of arterial thrombosis by aortography. Pediatrics. 1972;50:6–13.

    CAS  PubMed  Google Scholar 

  3. Flynn JT. Neonatal hypertension: diagnosis and management. Pedia Nephrol. 2000;14:332–41.

    Article  CAS  Google Scholar 

  4. Batisky DL. Neonatal hypertension. Clin Perinatol. 2014;41:529–42.

    Article  Google Scholar 

  5. Kent AL, Chaudhari T. Determinants of neonatal blood pressure. Curr Hypertens Rep. 2013;15:426–32.

    Article  Google Scholar 

  6. Flynn JT. Hypertension in the neonatal period. Curr Opin Pediatr. 2012;24:197–204.

    Article  Google Scholar 

  7. Friedman AL, Hustead VA. Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up. Pediatr Nephrol. 1987;1:30–34.

    Article  CAS  Google Scholar 

  8. Sahu R, Pannu H, Yu R, Shete S, Bricker JT, Gupta-Malhotra M. Systemic hypertension requiring treatment in the neonatal intensive care unit. J Pediatr. 2013;163:84–88.

    Article  Google Scholar 

  9. Sheftel DN, Hustead V, Friedman A. Hypertension screening in the follow-up of premature infants. Pediatrics. 1983;71:763–6.

    CAS  PubMed  Google Scholar 

  10. Singh HP, Hurley RM, Myers TF. Neonatal hypertension. Incidence and risk factors. Am J Hypertens. 1992;5:51–55.

    Article  CAS  Google Scholar 

  11. Jenkins RD, Aziz JK, Gievers LL, Mooers HM, Fino N, Rozansky DJ. Characteristics of hypertension in premature infants with and without chronic lung disease: a long-term multi-center study. Pediatr Nephrol. 2017;32:2115–24.

    Article  Google Scholar 

  12. Jenkins R, Tackitt S, Gievers L, Iragorri S, Sage K, Cornwall T, et al. Phthalate-associated hypertension in premature infants: a prospective mechanistic cohort study. Pediatr Nephrol. 2019;34:1413–24.

    Article  Google Scholar 

  13. Seliem WA, Falk MC, Shadbolt B, Kent AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol. 2007;22:2081–7.

    Article  Google Scholar 

  14. Abman SH, Warady BA, Lum GM, Koops BL. Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr. 1984;104:928–31.

    Article  CAS  Google Scholar 

  15. Alagappan A, Malloy MH. Systemic hypertension in very low-birth weight infants with bronchopulmonary dysplasia: incidence and risk factors. Am J Perinatol. 1998;15:3–8.

    Article  CAS  Google Scholar 

  16. Milstein JM, Goetzman BW, Riemenschneider TA, Wennberg RP. Increased systemic vascular resistance in neonates with pulmonary hypertension. Am J Cardiol. 1979;44:1159–62.

    Article  CAS  Google Scholar 

  17. Cohen G, Lagercrantz H, Katz-Salamon M. Abnormal circulatory stress responses of preterm graduates. Pediatr Res. 2007;61:329–34.

    Article  Google Scholar 

  18. Casey BJ, Duhoux S, Malter Cohen M. Adolescence: what do transmission, transition, and translation have to do with it? Neuron. 2010;67:749–60.

    Article  CAS  Google Scholar 

  19. Greenough A, Emery EF, Gamsu HR. Dexamethasone and hypertension in preterm infants. Eur J Pediatr. 1992;151:134–5.

    Article  CAS  Google Scholar 

  20. Al Awad E, Yusuf K, Soraisham A, Obaid H, Sundaram A, Samedi V, et al. Transient hyperaldosteronism and neonatal hypertension: case series and literature review. J Clin Neonatol. 2018;7:185–9.

    Article  Google Scholar 

  21. Stroustrup A, Bragg JB, Busgang SA, Andra SS, Curtin P, Spear EA, et al. Sources of clinically significant neonatal intensive care unit phthalate exposure. J Expo Sci Environ Epidemiol. 2018. https://doi.org/10.1038/s41370-018-0069-2. [Epub ahead of print].

  22. Mallow EB, Fox MA. Phthalates and critically ill neonates: device-related exposures and non-endocrine toxic risks. J Perinatol. 2014;34:892–7.

    Article  CAS  Google Scholar 

  23. Loff S, Subotic U, Reinicke F, Wischmann H, Brade J. Extraction of di-ethylhexyl-phthalate from perfusion lines of various material, length and brand by lipid emulsions. J Pediatr Gastroenterol Nutr. 2004;39:341–5.

    Article  CAS  Google Scholar 

  24. Weuve J, Sanchez BN, Calafat AM, Schettler T, Green RA, Hu H, et al. Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites. Environ Health Perspect. 2006;114:1424–31.

    Article  CAS  Google Scholar 

  25. Green R, Hauser R, Calafat AM, Weuve J, Schettler T, Ringer S, et al. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environ Health Perspect. 2005;113:1222–5.

    Article  CAS  Google Scholar 

  26. Zhao B, Chu Y, Huang Y, Hardy DO, Lin S, Ge RS. Structure-dependent inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 activities by phthalates. Chem Biol Interact. 2010;183:79–84.

    Article  CAS  Google Scholar 

  27. Walker BR, Edwards CR. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin N Am. 1994;23:359–77.

    Article  CAS  Google Scholar 

  28. Starr MC, Flynn JT. Neonatal hypertension: cases, causes, and clinical approach. Pediatr Nephrol. 2019;34:787–99.

    Article  Google Scholar 

  29. Coleman MM, Spear ML, Finkelstein M, Leef KH, Pearlman SA, Chien C, et al. Short-term use of umbilical artery catheters may not be associated with increased risk for thrombosis. Pediatrics. 2004;113:770–4.

    Article  Google Scholar 

  30. McAdams RM, Winter VT, McCurnin DC, Coalson JJ. Complications of umbilical artery catheterization in a model of extreme prematurity. J Perinatol. 2009;29:685–92.

    Article  CAS  Google Scholar 

  31. Shahid S, Dutta S, Symington A, Shivananda S, McMaster University N. Standardizing umbilical catheter usage in preterm infants. Pediatrics. 2014;133:e1742–1752.

    Article  Google Scholar 

  32. Chiellini F, Ferri M, Latini G. Physical-chemical assessment of di-(2-ethylhexyl)-phthalate leakage from poly(vinyl chloride) endotracheal tubes after application in high risk newborns. Int J Pharm. 2011;409:57–61.

    Article  CAS  Google Scholar 

  33. Latini G, De Felice C, Del Vecchio A, Barducci A, Ferri M, Chiellini F. Di-(2-ethylhexyl)phthalate leakage and color changes in endotracheal tubes after application in high-risk newborns. Neonatology. 2009;95:317–23.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the assistance of Drs Douglas Leonard, Declan O’Riordan, Scott Snyder, and Robert Schelonka for their support of this research in their neonatal units. The authors also thank Andrew Stout for his editing and proofreading assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Jenkins.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farnbach, K., Iragorri, S., Al-Uzri, A. et al. The changing spectrum of hypertension in premature infants. J Perinatol 39, 1528–1534 (2019). https://doi.org/10.1038/s41372-019-0457-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-019-0457-z

Search

Quick links